About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Biopharmaceutical Excipients Market Size & Growth Report | 2033
Biopharmaceutical Excipients Market

Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Excipient (Bulking Agents, Solubilizers and Surfactants, Buffering and Tonicity Agents, Others), By Biologics (Monoclonal Antibodies, Vaccines, Others), By Scale of Operation (Commercial, Research), By End-User (Pharma and Biotech Companies, CMOS and CDMOS, Academic and Research Institutes) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH3663DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Biopharmaceutical Excipients Market Introduction
    2. By Excipient
      1. Introduction
        1. Excipient By Value
      2. Bulking Agents
        1. By Value
      3. Solubilizers and Surfactants
        1. By Value
      4. Buffering and Tonicity Agents
        1. By Value
      5. Others
        1. By Value
    3. By Biologics
      1. Introduction
        1. Biologics By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Others
        1. By Value
    4. By Scale of Operation
      1. Introduction
        1. Scale of Operation By Value
      2. Commercial
        1. By Value
      3. Research
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharma and Biotech Companies
        1. By Value
      3. CMOS and CDMOS
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    1. Introduction
    2. By Excipient
      1. Introduction
        1. Excipient By Value
      2. Bulking Agents
        1. By Value
      3. Solubilizers and Surfactants
        1. By Value
      4. Buffering and Tonicity Agents
        1. By Value
      5. Others
        1. By Value
    3. By Biologics
      1. Introduction
        1. Biologics By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Others
        1. By Value
    4. By Scale of Operation
      1. Introduction
        1. Scale of Operation By Value
      2. Commercial
        1. By Value
      3. Research
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharma and Biotech Companies
        1. By Value
      3. CMOS and CDMOS
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. U.S.
      1. By Excipient
        1. Introduction
          1. Excipient By Value
        2. Bulking Agents
          1. By Value
        3. Solubilizers and Surfactants
          1. By Value
        4. Buffering and Tonicity Agents
          1. By Value
        5. Others
          1. By Value
      2. By Biologics
        1. Introduction
          1. Biologics By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Others
          1. By Value
      3. By Scale of Operation
        1. Introduction
          1. Scale of Operation By Value
        2. Commercial
          1. By Value
        3. Research
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharma and Biotech Companies
          1. By Value
        3. CMOS and CDMOS
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Canada
    1. Introduction
    2. By Excipient
      1. Introduction
        1. Excipient By Value
      2. Bulking Agents
        1. By Value
      3. Solubilizers and Surfactants
        1. By Value
      4. Buffering and Tonicity Agents
        1. By Value
      5. Others
        1. By Value
    3. By Biologics
      1. Introduction
        1. Biologics By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Others
        1. By Value
    4. By Scale of Operation
      1. Introduction
        1. Scale of Operation By Value
      2. Commercial
        1. By Value
      3. Research
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharma and Biotech Companies
        1. By Value
      3. CMOS and CDMOS
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. U.K.
      1. By Excipient
        1. Introduction
          1. Excipient By Value
        2. Bulking Agents
          1. By Value
        3. Solubilizers and Surfactants
          1. By Value
        4. Buffering and Tonicity Agents
          1. By Value
        5. Others
          1. By Value
      2. By Biologics
        1. Introduction
          1. Biologics By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Others
          1. By Value
      3. By Scale of Operation
        1. Introduction
          1. Scale of Operation By Value
        2. Commercial
          1. By Value
        3. Research
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharma and Biotech Companies
          1. By Value
        3. CMOS and CDMOS
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Excipient
      1. Introduction
        1. Excipient By Value
      2. Bulking Agents
        1. By Value
      3. Solubilizers and Surfactants
        1. By Value
      4. Buffering and Tonicity Agents
        1. By Value
      5. Others
        1. By Value
    3. By Biologics
      1. Introduction
        1. Biologics By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Others
        1. By Value
    4. By Scale of Operation
      1. Introduction
        1. Scale of Operation By Value
      2. Commercial
        1. By Value
      3. Research
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharma and Biotech Companies
        1. By Value
      3. CMOS and CDMOS
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. China
      1. By Excipient
        1. Introduction
          1. Excipient By Value
        2. Bulking Agents
          1. By Value
        3. Solubilizers and Surfactants
          1. By Value
        4. Buffering and Tonicity Agents
          1. By Value
        5. Others
          1. By Value
      2. By Biologics
        1. Introduction
          1. Biologics By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Others
          1. By Value
      3. By Scale of Operation
        1. Introduction
          1. Scale of Operation By Value
        2. Commercial
          1. By Value
        3. Research
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharma and Biotech Companies
          1. By Value
        3. CMOS and CDMOS
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Excipient
      1. Introduction
        1. Excipient By Value
      2. Bulking Agents
        1. By Value
      3. Solubilizers and Surfactants
        1. By Value
      4. Buffering and Tonicity Agents
        1. By Value
      5. Others
        1. By Value
    3. By Biologics
      1. Introduction
        1. Biologics By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Others
        1. By Value
    4. By Scale of Operation
      1. Introduction
        1. Scale of Operation By Value
      2. Commercial
        1. By Value
      3. Research
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharma and Biotech Companies
        1. By Value
      3. CMOS and CDMOS
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. UAE
      1. By Excipient
        1. Introduction
          1. Excipient By Value
        2. Bulking Agents
          1. By Value
        3. Solubilizers and Surfactants
          1. By Value
        4. Buffering and Tonicity Agents
          1. By Value
        5. Others
          1. By Value
      2. By Biologics
        1. Introduction
          1. Biologics By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Others
          1. By Value
      3. By Scale of Operation
        1. Introduction
          1. Scale of Operation By Value
        2. Commercial
          1. By Value
        3. Research
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharma and Biotech Companies
          1. By Value
        3. CMOS and CDMOS
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Excipient
      1. Introduction
        1. Excipient By Value
      2. Bulking Agents
        1. By Value
      3. Solubilizers and Surfactants
        1. By Value
      4. Buffering and Tonicity Agents
        1. By Value
      5. Others
        1. By Value
    3. By Biologics
      1. Introduction
        1. Biologics By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Others
        1. By Value
    4. By Scale of Operation
      1. Introduction
        1. Scale of Operation By Value
      2. Commercial
        1. By Value
      3. Research
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharma and Biotech Companies
        1. By Value
      3. CMOS and CDMOS
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. Brazil
      1. By Excipient
        1. Introduction
          1. Excipient By Value
        2. Bulking Agents
          1. By Value
        3. Solubilizers and Surfactants
          1. By Value
        4. Buffering and Tonicity Agents
          1. By Value
        5. Others
          1. By Value
      2. By Biologics
        1. Introduction
          1. Biologics By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Others
          1. By Value
      3. By Scale of Operation
        1. Introduction
          1. Scale of Operation By Value
        2. Commercial
          1. By Value
        3. Research
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharma and Biotech Companies
          1. By Value
        3. CMOS and CDMOS
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Biopharmaceutical Excipients Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Merck KGAA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. BASF SE
    3. Avantor
    4. Evonik Industries
    5. Roquette Freres
    6. Aceto
    7. Angus Chemical
    8. Apothecon
    9. Ashland Global
    10. BioSpectra
    11. BOC Sciences
    12. C.G. Group
    13. Clariant
    14. Colorcon
    15. DFE Pharma
    16. DOW
    17. Eastman Chemical
    18. IMCD N.V.
    19. Innophos
    20. Invitria
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Biopharmaceutical CMO And CRO Market Insights The global biopharmaceutical CMO And CRO market size was valued at USD 28.70 billion in 2021 and is projected to reach USD 51.36 billion by 2030, growing at a CAGR of 6.68% from 2022 to 2030.
Buy Now
Global Report
Market Overview The global biopharmaceutical logistics market size was valued at USD 118.45 billion in 2022. It is projected to reach USD 198.93 billion by 2031, growing at a CAGR of 5.93% during the forecast period (2023–2031). Biopharm
Buy Now
Global Report
Pharmaceutical Packaging Market Size The global Pharmaceutical Packaging Market Size was valued at USD 162.77 billion in 2024 and is projected to reach from USD 178.07 billion in 2025 to USD 365.37 billion by 2033, growing at a CAGR of 9.4% during t
Buy Now
Global Report
The global pharmaceuticals lipids market size was valued at USD 4.45 billion in 2021. It is projected to reach USD 7.07 billion by 2030, growing at a CAGR of 5.2% during the forecast period (2022–2030). In the pharmaceutical business, lipids a
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.